Editorial Team
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Editorial Team | Published : October 6, 2018 5:49 PM IST
. © Shutterstock
On October 5th, the US Food and Drug Administration (FDA) has allowed the marketing of a new hearing aid device. It can amplify sounds for individuals 18 years or older with perceived mild to moderate hearing loss. According to FDA, the Bose Hearing Aid is a user-fitted wireless air conduction hearing aid.
According to the Firstpost report, it is the first hearing aid approved by the agency that enables users to fit, programme and control the hearing aid on their own, without assistance from a health care provider.
The permanent or temporary hearing loss can be caused due to exposure to loud noises, ageing, certain medical conditions and other factors. To hear the speech and sounds individuals with permanent hearing loss can use hearing aids.
Air conduction hearing aids can capture sound vibrations through one or more microphones and the signal is processed, amplified, and played back through an earphone placed in the ear canal.
Through a mobile application on their phone patients can adjust the hearing aid through a mobile application. In real-time and in real-world environments without the assistance of a healthcare professional, this technology enables users to fit the hearing ais settings themselves.
The date of clinical studies of 125 patients has been reviewed by the FDA. The study finds that outcomes with self-fitting of the device are comparable on average to those with a professional fitting of the same device with respect to the amount of amplification selected, speech in noise testing and overall benefit.
